Marco Ruella: CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models

Marco Ruella, Assistant Professor Of Medicine and Scientific Director Lymphoma Program at the University of Pennsylvania, shared a post on X about a recent paper by Ruchi Patel et al. published in Science Immunology, commenting:

“Congrats to the now Dr. Ruchi Patel for the publication of her PhD thesis in Science Immunology. We show here that CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models.”

“CD5 deletion enhances the antitumor activity of adoptive T cell therapies”

Authors: Ruchi P. Patel, Guido Ghilardi, Yunlin Zhang, Patrizia Porazzi, Marco Ruella et al.

Source: Marco Ruella/X